Rockwell Medical, Inc. (RMTI), a health care company that distributes hemodialysis products, reported preliminary financial results showing a decline in revenue in the fourth quarter and full year 2025 compared to the year-ago period. However, gross margin improved.
Despite the mixed news, RMTI is surging 24.31%, at $1.17 in the premarket.
For the fourth quarter, Rockwell expects net sales of approximately $18.6 million, down from $24.7 million reported in the prior year.
For the full-year 2025, the expected net sales are approximately $69.5 million, lower than the $101.5 million reported a year ago.
Gross margin for the fourth quarter increased to approximately 22% from 15% in the prior year.
As of December 2025, Rockwell held cash, cash equivalents, and investments available-for-sale are expected to increase to approximately $25 million.
"As we look to 2026, we are focused on three main areas: revenue growth, increased profitability, and portfolio diversification," said Mark Strobeck, Ph.D., President and CEO of Rockwell Medical.
RMTI closed Friday's trade at $0.95,up 0.75%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.